Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction

Authors

Xiaopu Zhou, Hong Kong University of Science and Technology
Yu Chen, Hong Kong University of Science and Technology
Fanny C.F. Ip, Hong Kong University of Science and Technology
Yuanbing Jiang, Hong Kong University of Science and Technology
Han Cao, Hong Kong University of Science and Technology
Ge Lv, Hong Kong University of Science and Technology
Huan Zhong, Hong Kong University of Science and Technology
Jiahang Chen, Hong Kong University of Science and Technology
Tao Ye, Hong Kong University of Science and Technology
Yuewen Chen, Hong Kong University of Science and Technology
Yulin Zhang, Hong Kong University of Science and Technology, Shenzhen Research Institute
Shuangshuang Ma, Hong Kong University of Science and Technology, Shenzhen Research Institute
Ronnie M.N. Lo, Hong Kong University of Science and Technology
Estella P.S. Tong, Hong Kong University of Science and Technology
Ansgar J. Furst, Stanford University
Joy L. Taylor, Stanford University
Jerome A. Yesavage, Stanford University
Gail Li, The Ohio State University
Eric C. Petrie, The Ohio State University
Elaine R. Peskind, University of Washington
Sandra Harding, University of Wisconsin-Madison
J. Jay Fruehling, University of Wisconsin-Madison
Dino Massoglia, Medical University of South Carolina
Olga James, Duke University Medical Center
Konstantinos Arfanakis, Rush University Medical Center
Debra Fleischman, Rush University Medical Center
Karl Friedl
Shannon Finley, University of California, San Francisco
Jacqueline Hayes, University of California, San Francisco
Rosemary Morrison, University of California, San Diego
Melissa Davis, University of California, San Diego
Jordan Grafman, Northwestern University
Thomas Neylan, University of California, San Francisco
Balebail Ashok Raj, Byrd Alzheimer’s Center and Research Institute

Document Type

Article

Publication Date

12-1-2023

Abstract

Background: The polygenic nature of Alzheimer’s disease (AD) suggests that multiple variants jointly contribute to disease susceptibility. As an individual’s genetic variants are constant throughout life, evaluating the combined effects of multiple disease-associated genetic risks enables reliable AD risk prediction. Because of the complexity of genomic data, current statistical analyses cannot comprehensively capture the polygenic risk of AD, resulting in unsatisfactory disease risk prediction. However, deep learning methods, which capture nonlinearity within high-dimensional genomic data, may enable more accurate disease risk prediction and improve our understanding of AD etiology. Accordingly, we developed deep learning neural network models for modeling AD polygenic risk. Methods: We constructed neural network models to model AD polygenic risk and compared them with the widely used weighted polygenic risk score and lasso models. We conducted robust linear regression analysis to investigate the relationship between the AD polygenic risk derived from deep learning methods and AD endophenotypes (i.e., plasma biomarkers and individual cognitive performance). We stratified individuals by applying unsupervised clustering to the outputs from the hidden layers of the neural network model. Results: The deep learning models outperform other statistical models for modeling AD risk. Moreover, the polygenic risk derived from the deep learning models enables the identification of disease-associated biological pathways and the stratification of individuals according to distinct pathological mechanisms. Conclusion: Our results suggest that deep learning methods are effective for modeling the genetic risks of AD and other diseases, classifying disease risks, and uncovering disease mechanisms.

This document is currently not available here.

Share

COinS